BA.2.75.2 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

665 results for “BA.2.75.2”

Trials

View all 225 →

Atoguanil BA Study

16 participants · First posted Apr 30, 2021

Biliary Atresia With Rare Associations, a Case Report

1 participants · First posted Jun 23, 2023

CTRI/2017/05/008702

A study on 28 healthy adult males to check the concentration of different forms of Curcumin in their blood.

28 participants

Drugs

View all 125 →

BA-1302

BA-1105

BA-1202

Organizations

View all 242 →

Xinjiang Ba Yi Iron ＆ Steel Co.,Ltd.

Boston Analytical, Inc.

United States

University of Minnesota Medical School

United States

News

View all 73 →

FDA Restricts Emergency Use Authorization for AstraZeneca's Evusheld in the US

FDA Limits GSK's Xevudy Authorization Due to BA.2 Variant Concerns

Beyond Air's NeuroNOS Receives FDA Orphan Drug Designation for Glioblastoma Therapy BA-101

Page 1 of 67